EUVIMEDEUVIMED entdecken
Open Access

Assessment of Obesity-related Metabolic Conditions: a novel objective scoring system better informs metabolic disease severity

Victoria Lyo, John Arriola, Shushmita M Ahmed, Rouzbeh Mostaedi, Zainab Akinjobi, Hazem N Shamseddeen, Mohamed R Ali

Surgery for Obesity and Related Diseases · 2025

DOI: 10.1016/j.soard.2024.09.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery for Obesity and Related Diseases, 2025. Verfasst von Victoria Lyo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California, Davis, California; Center for Alimentary and Metabolic Sciences, University of California, Davis, Ca…. Hauptthemen laut MEDLINE: Obesity, Morbid, Obesity, Metabolic Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NICHD NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Reporting of obesity-associated metabolic disease severity and longitudinal response to bariatric surgery is not standardized. We updated our co-morbidity scoring tool to the Assessment of Obesity-related Metabolic Conditions (AOMC) to combine pharmacotherapy and biochemical data to score diabetes mellitus (DM), hypertension (HTN), and dyslipidemia (DYS) severity. OBJECTIVES: The aim of this study is to determine whether the AOMC system more accurately stages metabolic disease severity than a clinically based Assessment of Obesity-Related Comorbidities (AORC) system. SETTING: University hospital, United States. METHODS: A retrospective cohort study of prospectively collected demographic, clinical, and biochemical data was performed on adults evaluated for bariatric surgery over 6years. AORC versus AOMC scores and disease severity were compared using McNemar's and Wilcoxon's tests. RESULTS: Of 1442 patients, AOMC newly diagnosed metabolic disease in more patients than did AORC: DM (73.4% versus 44.5%), HTN (91.7% versus 67.9%), and DYS (63.8% versus 53.4%). Of those on pharmacotherapy, AOMC found fewer patients with adequately controlled disease: DM (39.9% versus 97.7%), HTN (64.7% versus 99.3%), and DYS (51.8% versus 99.0%). For those in whom both scores could be calculated, disease severity was upstaged in most patients: DM (65.9%), HTN (42.9%), and DYS (30.9%). There were also significant shifts toward higher scores for all conditions and severity classifications, with more patients diagnosed with pre-metabolic and severe disease (untreated/uncontrolled). CONCLUSIONS: Our study demonstrated that the severity of DM, HTN, and DYS is vastly under-represented by clinical history alone and lacks standardized assessments. Our AOMC tool more accurately describes longitudinal metabolic response to bariatric surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Obesity, MorbidObesityMetabolic DiseasesHumansFemaleMaleRetrospective StudiesMiddle AgedSeverity of Illness IndexAdultBariatric SurgeryHypertensionDyslipidemiasComorbidityDiabetes Mellitus

Stichwörter der Autor:innen

DiabetesDyslipidemiaHypertensionMetabolic diseaseObjective assessmentResponse to bariatric surgery

Autor:innen und Institutionen

  • Department of Surgery, University of California, Davis, California; Center for Alimentary and Metabolic Sciences, University of California, Davis, California.
  • Department of Surgery, University of California, Davis, California.
  • Kaiser Permanente, Richmond, California.
  • Department of Public Health Sciences, University of California, Davis, California.
  • Department of Surgery, University of California, Davis, California; Center for Alimentary and Metabolic Sciences, University of California, Davis, California. Electronic address: mrali@ucdavis.edu.

Förderung

  • NIAMS NIH HHS
  • NICHD NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Lyo, V., Arriola, J., Ahmed, S. M., Mostaedi, R., Akinjobi, Z., Shamseddeen, H. N., & Ali, M. R. (2025). Assessment of Obesity-related Metabolic Conditions: a novel objective scoring system better informs metabolic disease severity. Surgery for Obesity and Related Diseases. https://doi.org/10.1016/j.soard.2024.09.004

Vancouver

Lyo V, Arriola J, Ahmed SM, Mostaedi R, Akinjobi Z, Shamseddeen HN, et al. Assessment of Obesity-related Metabolic Conditions: a novel objective scoring system better informs metabolic disease severity. Surgery for Obesity and Related Diseases. 2025. doi:10.1016/j.soard.2024.09.004

BibTeX
@article{Lyo2025,
  author = {Lyo, Victoria and Arriola, John and Ahmed, Shushmita M and Mostaedi, Rouzbeh and Akinjobi, Zainab and Shamseddeen, Hazem N and Ali, Mohamed R},
  title = {Assessment of Obesity-related Metabolic Conditions: a novel objective scoring system better informs metabolic disease severity},
  journal = {Surgery for Obesity and Related Diseases},
  year = {2025},
  doi = {10.1016/j.soard.2024.09.004}
}
Kostenlos starten →